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Background: In the later stages of circulatory shock, monitoring should help to avoid fluid overload. In this setting,
volume expansion is ideally indicated only for patients in whom the cardiac index (CI) is expected to increase.
Crystalloids are usually the choice for fluid replacement. As previous studies evaluating the hemodynamic effect of
crystalloids have not distinguished responders from non-responders, the present study was designed to evaluate
the duration of the hemodynamic effects of crystalloids according to the fluid responsiveness status.
Methods: This is a prospective observational study conducted after the initial resuscitation phase of circulatory
shock (>6 h vasopressor use). Critically ill, sedated adult patients monitored with a pulmonary artery catheter who
received a fluid challenge with crystalloids (500 mL infused over 30 min) were included. Hemodynamic variables
were measured at baseline (T0) and at 30 min (T1), 60 min (T2), and 90 min (T3) after a fluid bolus, totaling 90 min
of observation. The patients were analyzed according to their fluid responsiveness status (responders with CI
increase >15% and non-responders ≤15% at T1). The data were analyzed by repeated measures of analysis
of variance.
Results: Twenty patients were included, 14 of whom had septic shock. Overall, volume expansion significantly
increased the CI: 3.03 ± 0.64 L/min/m2 to 3.58 ± 0.66 L/min/m2 (p < 0.05). From this period, there was a
progressive decrease: 3.23 ± 0.65 L/min/m2 (p < 0.05, T2 versus T1) and 3.12 ± 0.64 L/min/m2 (p < 0.05, period
T3 versus T1). Similar behavior was observed in responders (13 patients), 2.84 ± 0.61 L/min/m2 to 3.57 ± 0.65 L/min/m2
(p < 0.05) with volume expansion, followed by a decrease, 3.19 ± 0.69 L/min/m2 (p < 0.05, T2 versus T1) and 3.06 ±
0.70 L/min/m2 (p < 0.05, T3 versus T1). Blood pressure and cardiac filling pressures also decreased significantly after
T1 with similar findings in both responders and non-responders.
Conclusions: The results suggest that volume expansion with crystalloids in patients with circulatory shock after the
initial resuscitation has limited success, even in responders.
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Intravascular fluid administration is the first-line interven-
tion for the restoration of hemodynamic stability in critic-
ally ill patients [1]. The expected response to fluid infusion
is an increase in venous return leading to an augmentation
of cardiac output (CO) through the Frank-Starling mechan-
ism [2]. However, only half of all hemodynamically un-
stable patients are preload-responsive [3]. This phenomenon
could be particularly important in patients who are in the
intensive care unit (ICU) for several hours or days after
the initial resuscitation. At this stage, especially if a lung is
injured, positive fluid balance becomes a major concern.
In this case, it is recommended to use predictors of fluid
responsiveness to distinguish between patients who can
benefit from volume expansion (responders) and those in
whom fluid loading can be futile and even deleterious
(non-responders) [4].
However, even in responders, using fluids after the initial
resuscitation to treat hypotension or indices of inadequate
tissue perfusion could be inappropriate. Two factors justify
this concern: First, fluid administration can lead to an
increased fluid balance, which is associated with a worse
outcome in ICU patients [5,6]. Second, isotonic crystalloid
solutions, usually the choice for fluid replacement, have a
limited effect on plasma volume. In theory, after a short
period of balance, only approximately 20% of an intraven-
ously infused crystalloid solution will remain in the intra-
vascular space to support plasma volume [7].
Studies designed to examine fluid responsiveness only
address the immediate hemodynamic response to a fluid
challenge. Moreover, previous studies evaluating the
hemodynamic effect of crystalloids have not distinguished
responders from non-responders. The present study aimed
to evaluate the short-term hemodynamic effects of volume
expansion with crystalloids after the initial resuscitation of
circulatory shock in patients receiving vasopressors and to
compare these effects in responders and non-responders.
Methods
This observational study was conducted in a 35-bed mixed
ICU in a university hospital. The institutional Research
and Ethics Committee (Universidade Federal de São Paulo)
approved the study, and informed consent was waived due
to its purely observational nature.
We prospectively included adult patients with circula-
tory shock who received one fluid challenge with crystal-
loids (Ringer's lactate or sodium chloride 0.9% solution,
500 mL infused over 30 min) indicated for inadequate tis-
sue perfusion by the attending physician. Only patients
treated with vasopressors for at least 6 h, under mechanical
ventilation, receiving continuous sedation (Ramsay score
5 to 6), and monitored with an arterial catheter and a
pulmonary artery catheter (Edwards Lifesciences, Irvine,
CA, USA) were eligible for study inclusion. We excludedpatients in whom the primary cause of hypotension was
active bleeding (suspected or confirmed), burn injury, and
cardiogenic shock, defined as cardiac index (CI) <1.8 L/
min/m2 without support and pulmonary artery occlusion
pressure ≥18 mmHg.
The patients were followed during fluid infusion (30 min)
and for 60 min after. Throughout this observational period,
if the attending physician changed ventilator parameters,
doses of the sedative, inotropic and vasopressor medica-
tions or administered a new volume expansion, the patient
was excluded from the analysis.
As part of the routine care, we registered a complete
set of hemodynamic and respiratory measurements, in-
cluding arterial and mixed venous blood gases, and
hemoglobin and arterial lactate levels at the beginning (T0)
and end of the volume expansion (T1). Only hemodynamic
measurements were registered at 60 min (T2) and 90 min
(T3). Thus, the study has four different time points:
baseline (T0), 30 min (T1), 60 min (T2), and 90 min
(T3) after the fluid bolus, totaling 90 min of observa-
tion. Patients who did not have laboratory samples
collected before and after the fluid infusion were ex-
cluded from the analysis.
The CI was measured using a semi-continuous ther-
modilution technique considering the average value of
four consecutive measurements from the STAT mode
screen of the Vigilance® monitor (Edwards Lifesciences,
Irvine, CA, USA). We also measured the pulse pressure
variation (PPV) in patients without limitations to this as-
sessment, with a multiparameter bedside monitor (DX
2020, Dixtal, São Paulo, Brazil) using the automatic method
[8,9]. All pressures were determined using the cursor line
of the bedside monitor screen. The reference point for
right atrial pressure (RAP) and pulmonary artery occlu-
sion pressure (PAOP) was the base of the ‘a’ wave at the
end-expiration phase with the zero reference level settled
at the mid-chest and the head of the bed elevated at ap-
proximately 30°.
Statistical analysis
Data are expressed as numbers (%), means ± standard de-
viation (SD), or medians and interquartile ranges (25th to
75th percentile), as appropriate. Changes in CI after the
fluid infusion were expressed as percentages. The distribu-
tion of continuous variables was assessed by the Shapiro-
Wilk test.
A one-way repeated measures analysis of variance
(ANOVA) was used to compare the hemodynamic vari-
ables in different time points (T0, T1, T2, and T3). Second,
the patients were divided into two subgroups according
to the percent increase in CI in response to volume ex-
pansion: ‘responders’ had a CI increase of at least 15%,
whereas ‘non-responders’ had a CI increase of less than
15%. A two-way repeated measure ANOVA (to include a
Table 1 Patient characteristics at baseline
Patient characteristic Data
Age (years) 63.7 ± 14.2
Gender [male (%)] 16 (80)
APACHE II 21.50 (18.0 to 26.0)
SOFA 10.5 (9.0 to 12.0)
PEEP (cm H2O) 8.0 (5.0 to 10.0)
FiO2 (%) 40 (40 to 50)
Tidal volume (mL) 487 ± 95.1
Cstat (mL/cm H2O) 39.2 ± 13.5
PaO2/FiO2 206.6 ± 72.9
Time of vasopressor use (h) 25.0 (19.5 to 34.0)
Fluid balance (mL)a 7,217 (6,345 to 8,545)
Causes of shock
Sepsis [n (%)] 14 (70)
Major surgery [n (%)] 5 (25)
Multiple trauma [n (%)] 1 (5)
Catecholamine infusion
Norepinephrine, μg/kg/min (n = 20) 0.33 (0.21 to 0.83)
Epinephrine, μg/kg/min (n = 5) 0.26 (0.14 to 0.35)
Dobutamine, μg/kg/min (n = 5) 6.0 (5.1 to 7.1)
Survivors (ICU) [n (%)] 7 (35)
APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential
Organ Failure Assessment score; PEEP, positive end-expiratory pressure; FiO2,
fraction of inspired oxygen; Cstat, static respiratory compliance; PaO2, partial
pressure of oxygen; ICU, intensive care unit. aFrom shock to fluid infusion.
Quantitative variables are expressed as means (SD) or medians (IQR 25th to
75th percentile).
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Bonferroni adjustment for multiple comparisons.
When only measurements at T0 and T1 were available
(hemoglobin, lactate, and mixed venous oxygen satur-
ation), we used Mann-Whitney U test or a t test to com-
pare responders and non-responders at baseline and
Wilcoxon’s rank-sum test or a paired t test to assess the
effects of intravascular volume expansion.
We used SPSS version 17.0 for Windows (SPSS Inc.,
Chicago, IL, USA). The results with p values of <0.05 were
considered to be significant.
Results
From September 2011 to January 2013, 84 patients with
circulatory shock were monitored with a pulmonary ar-
tery catheter in the ICU, of whom 20 patients were in-
cluded (Figure 1).
The circulatory shock was secondary to sepsis (n = 14),
major surgery (n = 5), or multiple trauma (n = 1). The me-
dian duration of vasopressor use before inclusion was 25
(19.5 to 34.0) h. The fluid balance from the time when
vasopressor treatment was initiated to volume expansion
was 7,217 (6,345 to 8,545) mL. There was no difference
between responders and non-responders regarding the
duration of shock (p = 0.59) and fluid balance (p = 0.81).
Patient characteristics are listed in Table 1.
The indications for volume expansion were hyperlacta-
temia (30%), hypotension (20%), clinical signs of poor skin
perfusion (20%), reduce vasopressors (20%), and oliguria
(10%). The diuresis during study period was 37.50 (0.00 to
97.50) mL, with no differences between responders and
non-responders (p = 0.77).Figure 1 Study flowchart. PAC, pulmonary artery catheter; ICU, intensive care unit.
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sion; however, in T3, CI decreased to the baseline values
(Figure 2). Cardiac filling pressures and mean arterial
pressure (MAP) also increased significantly in T1 and
decreased after volume expansion (T2 and T3) (Table 2).
Thirteen patients were considered to be volume re-
sponders, as their CI increased more than 15%. CI did
not change over time in non-responders group, whereas
in responders CI changed significantly: after an initial in-
crease from T0 to T1, there was a reduction in T2 and
T3. Cardiac filling pressures and MAP were similar be-
tween responders and non-responders over time. These
variables decreased after volume expansion (T2 and T3)
toward baseline values. Responders and non-responders
showed no significant change in heart rate (HR) over
time (Table 3).
All patients were in sinus rhythm, and only one had
ventricular extrasystoles not allowing automatic PPV
measurement. We also did not record PPV in other 14 pa-
tients because of spontaneous ventilation or ventilation
with low tidal volume. Thus, PPV could be registered only
in five patients. The four responders at baseline were not
fluid-responsive at T1 (PPV < 12%).
Discussion
The main finding of our study was that CI decreased to-
ward baseline values 60 min after fluid infusion. Even in
responders, the hemodynamic changes nearly disap-
peared in this period. The results strengthen the body of
evidence that shows a short hemodynamic effect after
volume expansion with crystalloids.
As there were no acute fluid losses, the main finding
of our study has some possible explanations. First, crys-
talloids have limited intravascular volume effect, as sug-
gested by volume kinetics studies of Ringer’s solution
[10-13]. This has been demonstrated even in normal vas-
cular endothelial conditions. A study in healthy volunteers
demonstrated that 68% of the saline infused (1,000 mL
over 60 min) had escaped from the intravascular to theFigure 2 Cardiac index. CI, cardiac index. Baseline, 3.03 ± 0.64; T1,
3.58 ± 0.66; T2, 3.23 ± 0.65; T3, 3.12 ± 0.64. *p < 0.05 versus baseline,
+p < 0.05 versus T1.extravascular space at the end of infusion, as estimated
from hematocrit/hemoglobin changes [12]. According to
another study, in healthy volunteers who received lactated
Ringer’s solution (1,000 mL over 5 to 7 min) after blood
withdrawal, the peak increase in the intravascular volume
occurred immediately after completion of infusion (630 ±
127 mL), and the intravascular volume expanding effect
declined rapidly after its initial peak (only 403 ± 88 mL
by 15 min) [13]. Second, under inflammatory conditions,
such as sepsis, surgery, or trauma, the damage of the
endothelial glycocalyx decreases vascular barrier function
and leads to protein extravasation [14,15]. In these
settings, the hemodynamic effects of crystalloid may be
smaller. In postoperative hypovolemic patients, Ringer’s
solution (10 mL/kg over 30 min) significantly improved
hemodynamics at the end of volume loading, but this
effect completely disappeared at 120 min [16]. One im-
portant point is that there might be different behaviors
among our patients, depending on the origin of shock, the
degree of vasodilation, the supposed degree of capillary
leak, and the shock severity.
A number of experimental and clinical studies, gener-
ally comparing crystalloids with colloid solutions, have
reached similar conclusions through different monitor-
ing tools and endpoints [12,13,16-20]. In these studies,
the hemodynamic effects of colloids lasted longer than
those of crystalloids. In general, colloid administration
restores hemodynamic stability more rapidly and with less
volume in a variety of clinical conditions [17-20]. Despite
theoretical benefits favoring colloids over crystalloids to
achieve resuscitation endpoints, this advantage is not as
clear in clinical application [21,22]. Comparisons in pa-
tients with capillary leak show that the ratio between re-
quired volumes in the crystalloid and colloid is in a range
between 1 and 2 (not threefold or higher ratio as recom-
mended by textbooks) [21]. Moreover, there are concerns
about the safety of synthetic colloids [23-26]. Thus, we
chose to evaluate only the use of fluid challenges with
crystalloids in this study.
Rather than increasing the plasma volume or reaching
static parameters of preload, the main reason for intravas-
cular fluid administration is to increase stroke volume. If
the fluid challenge does not increase stroke volume, the
volume loading is useless to the patient [1]. In our sample,
volume expansion led to an immediate increase in cardiac
filling pressures in all patients and significantly increased
CI in a subset of them (responders). This result aligns with
studies designed to examine fluid responsiveness [27-29].
However, these studies only describe the effect of volume
expansion immediately at the end of infusion. We demon-
strated a rapid CI reduction after this time point in all re-
sponders. RAP decreased after volume expansion as
compared to T1 values. PAOP and MAP were similar to
baseline values at T3. Our findings suggest that post-
Table 2 Time-course of hemodynamic variables (all patients)
Variables T0 (baseline) T1 (30 min) T2 (60 min) T3 (90 min)
RAP (mmHg) 8.20 ± 3.02 10.5 ± 3.17* 9.0 ± 3.06*,+ 9.10 ± 4.00*,+
PAOP (mmHg) 8.52 ± 3.16 10.13 ± 3.71* 8.81 ± 3.15+ 8.67 ± 3.36+
MAP (mmHg) 73.70 ± 8.18 81.70 ± 9.64* 77.95 ± 10.28* 77.60 ± 13.05
HR (beats/min) 109 ± 18.48 106.15 ± 18.11 107.35 ± 19.20 107.55 ± 19.45
SvO2 (%) 66.30 ± 9.03 69.07 ± 7.98*
Lactate (mg/dL) 3.44 (1.92 to 5.47) 3.0 (1.86 to 5.53)
Hb (g/dL) 9.59 ± 1.62 9.17 ± 1.80
RAP, right atrial pressure; PAOP, pulmonary artery occlusion pressure; MAP, mean arterial pressure; HR, heart rate; SvO2, mixed venous oxygen saturation; Hb,
hemoglobin. *p < 0.05 versus baseline, +p < 0.05 versus T1. Data are expressed as means (SD) or medians (IQR 25th to 75th percentile).
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latory shock has limited impact.
Our study was performed after the resuscitation phase. It
is unclear whether hemodynamic effects would be sustained
for longer in the initial resuscitation phase. Hypotensive
septic patients who received 5 mL/kg of normal saline over
15 min had a sustained increase in CO within 120 min [30].
However, experimental models of septic shock suggest dif-
ferent results [31,32]. Our findings allow us to speculate
that repeated volume expansions would be required in re-
sponders to sustain CO. Interestingly, studies performed
in the context of goal-directed therapy in the perioperative
period demonstrated that minimizing stroke volume vari-
ation by volume loading, and thus sustaining CO, was as-
sociated with increased fluid administration [33-36].Table 3 Time-course of hemodynamic variables according to
Variable T0 (baseline)
CI (L/min/m2) R 2.84 ± 0.61
NR 3.40 ± 0.55
RAP (mmHg) R 8.54 ± 3.36
NR 7.57 ± 2.37
PAOP (mmHg) R 8.77 ± 3.30
NR 8.04 ± 3.08
MAP (mmHg) R 74.62 ± 6.84
NR 72.00 ± 10.63
HR (beats/min) R 107.54 ± 19.83
NR 111.71 ± 16.80
Lactate (mmol/L) R 2.78 (1.50 to 6.89)
NR 3.44 (2.22 to 4.22)
Hb (g/dL) R 9.36 ± 1.76
NR 10.01 ± 1.36
SvO2 (%) R 63.00 ± 9.08
NR 72.46 ± 5.02
R, responders; NR, non-responders; CI, cardiac index; RAP, right atrial pressure; PAO
rate; SvO2, mixed venous oxygen saturation; Hb, hemoglobin. The groups (R and NR
over time in NR (p = 0,306). The groups (R and NR) showed no significant difference
MAP, and HR were similar between R and NR at T0, T1, T2, and T3 (p > 0.05). The gr
groups (R and NR) showed no significant difference in lactate levels (p = 0.72) and H
expressed as means (SD) or medians (IQR 25th to 75th percentile).We can suggest that we should be more judicious in pur-
suing volume expansion in the post-resuscitation phase,
even in responders. Excessive intravenous fluid therapy
leading to positive fluid balances and interstitial edema
could be associated with adverse outcomes in critically ill
patients [37-40]. In contrast to hypodynamic circulation,
as seen in early severe sepsis [41], late-phase patients usu-
ally have elevated RAP, CO, and mixed venous oxygen sat-
uration (SvO2) [42,43]. It has been suggested that the
preferred use of vasoactive drugs may be an acceptable ap-
proach for such late-phase patients [39].
The current study has an important strength. In contrast
with previous studies, we described the hemodynamic ef-
fects of volume expansion according to a fluid responsive-
ness status (CI response to volume expansion). Previousfluid responsiveness status
T1 (30 min) T2 (60 min) T3 (90 min)
3.57 ± 0.65* 3.19 ± 0.69*,+ 3.06 ± 0.70+
3.59 ± 0.74 3.31 ± 0.61 3.24 ± 0.55
10.23 ± 3.72* 9.08 ± 3.59*,+ 9.23 ± 3.54*,+
9.71 ± 1.98* 8.86 ± 1.95*,+ 8.86 ± 2.27*,+
10.64 ± 4.03* 8.69 ± 3.2 8.89 ± 3.62
9.17 ± 3.06* 9.01 ± 3.30 8.26 ± 3.05
83.92 ± 8.20* 79.62 ± 10.94 79.77 ± 14.02
77.57 ± 11.36* 74.86 ± 8.84 73.57 ± 10.83
105.77 ± 19.63 107.85 ± 20.43 108.62 ± 21.06
106.86 ± 16.31 106.43 ± 18.17 105.57 ± 17.42
2.78 (1.56 to 6.72)
3.44 (2.22 to 5.11)
9.34 ± 2.06
8.83 ± 1.26*
66.30 ± 8.30*
74.20 ± 4.01
P, pulmonary artery occlusion pressure; MAP, mean arterial pressure; HR, heart
) showed significant CI difference over time (p = 0.009). The CI did not change
over time in RAP, PAOP, MAP, and HR (p > 0.05). Mean values of RAP, PAOP,
oups (R and NR) showed significant difference in SvO2 (p = 0.02) at T0. The
b (p = 0.46) at T0. *p < 0.05 versus baseline, +p < 0.05 versus T1. Data are
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methods or static preload parameters as endpoint, which
might have limited applicability. Our study also had limita-
tions. The first and main limitation was the sample size. A
larger sample might have further strengthened our results.
Second, the amount of infused fluid (500 mL of crystalloids
over 30 min) might have not been enough to impact the
CI [44]. However, in our study, there was a significant
increase in RAP, and the fluid administration was able
to significantly increase the CI in 13 patients. Moreover, in
responders whom PPV was measured, the value fell below
12% in all. Third, we did not have hemoglobin/hematocrit
values at different time points (T0, T1, T2, and T3) to cal-
culate changes in blood volume, which could enhance our
findings. Fourth, we could not fully assess cardiac function
using echocardiography before and after fluid challenge to
rule out the presence of previous cardiac dysfunction that
could be aggravated by the circulatory shock. Finally, we
use a semi-continuous thermodilution technique for de-
termining the CO. This method may underestimate the
changes in CO if it is measured immediately after the fluid
infusion. As the patient was followed for 90 min, this
limitation most likely did not affect the conclusions
of the study.
Conclusions
In patients with circulatory shock after an initial resusci-
tation, our findings suggest that the hemodynamic ef-
fects of crystalloid administration are not sustained after
60 min, even in responders.
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